Search Results - "Bykov, M. S."

Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women by Bateman, Brian T., MD, MSc, Franklin, Jessica M., PhD, Bykov, Katsiaryna, PharmD, MS, Avorn, Jerry, MD, Shrank, William H., MD, MSHS, Brennan, Troyen A., MD, JD, MPH, Landon, Joan E., MS, Rathmell, James P., MD, Huybrechts, Krista F., MS, PhD, Fischer, Michael A., MD, MS, Choudhry, Niteesh K., MD, PhD

“…Background The incidence of opioid-related death in women has increased 5-fold over the past decade. For many women, their initial opioid exposure will occur…”
Get full text

Patterns and predictors of persistent opioid use following hip or knee arthroplasty by Kim, Seoyoung C., MD, ScD, MSCE, Choudhry, Niteesh, MD, PhD, Franklin, Jessica M., PhD, Bykov, Katsiaryna, PharmD, MS, Eikermann, Matthias, MD, Lii, Joyce, MS, MA, Fischer, Michael A., MD, MS, Bateman, Brian T., MD, MSc

“…Summary Objective The relationship between arthroplasty and long-term opioid use in patients with knee or hip osteoarthritis is not well studied. We examined…”
Get full text

Impact of an Interaction Between Clopidogrel and Selective Serotonin Reuptake Inhibitors by Bykov, Katsiaryna, PharmD, MS, Schneeweiss, Sebastian, MD, ScD, Donneyong, Macarius M., MPH, PhD, Dong, Yaa-Hui, PhD, Choudhry, Niteesh K., MD, PhD, Gagne, Joshua J., PharmD, ScD

“…Abstract Clopidogrel is a pro-drug that requires activation by the cytochrome P450 (CYP) enzyme system. Patients receiving clopidogrel are often treated with…”
Get full text

Treatment Dynamics of Newly Marketed Drugs and Implications for Comparative Effectiveness Research by Gagne, Joshua J., PharmD, ScD, Bykov, Katsiaryna, PharmD, MS, Willke, Richard J., PhD, Kahler, Kristijan H., RPh, PhD, Subedi, Prasun, PhD, Schneeweiss, Sebastian, MD, ScD

“…Abstract Objectives Clinicians and payers require rapid comparative effectiveness (CE) evidence generation to inform decisions for new drugs. We empirically…”
Get full text

A Unified Framework for Classification of Methods for Benefit-Risk Assessment by Najafzadeh, Mehdi, PhD, Schneeweiss, Sebastian, MD, ScD, Choudhry, Niteesh, MD, PhD, Bykov, Katsiaryna, PharmD, MS, Kahler, Kristijan H., RPh, PhD, Martin, Diane P., PhD, Gagne, Joshua J., PharmD, ScD

“…Abstract Background Patients, physicians, and other decision makers make implicit but inevitable trade-offs among risks and benefits of treatments. Many…”
Get full text

Comparison of Benefit-Risk Assessment Methods for Prospective Monitoring of Newly Marketed Drugs: A Simulation Study by Gagne, Joshua J., PharmD, ScD, Najafzadeh, Mehdi, PhD, Choudhry, Niteesh K., MD, PhD, Bykov, Katsiaryna, PharmD, MS, Kahler, Kristijan H., PhD, Martin, Diane, PhD, Rogers, James R, Schneeweiss, Sebastian, MD, ScD

“…Abstract Objectives To compare benefit-risk assessment (BRA) methods for determining whether and when sufficient evidence exists to indicate that one drug is…”
Get full text

Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery by Bateman, Brian T., MD, Rassen, Jeremy A., ScD, Schneeweiss, Sebastian, MD, ScD, Bykov, Katsiaryna, PharmD, MS, Franklin, Jessica Myers, PhD, Gagne, Joshua J., PharmD, ScD, Polinski, Jennifer M., ScD, MPH, Liu, Jun, MD, MPH, Kulik, Alexander, MD, MPH, Fischer, Michael A., MD, MS, Choudhry, Niteesh K., MD, PhD

“…Objective The incidence of hospital-acquired Clostridium difficile infection (CDI) has increased rapidly over the past decade; patients undergoing major…”
Get full text

Prospective Benefit-Risk Monitoring of New Drugs for Rapid Assessment of Net Favorability in Electronic Health Care Data by Gagne, Joshua J., PharmD, ScD, Bykov, Katsiaryna, PharmD, MS, Najafzadeh, Mehdi, PhD, Choudhry, Niteesh K., MD, PhD, Martin, Diane P., PhD, Kahler, Kristijan H., PhD, Rogers, James R., BA, BS, Schneeweiss, Sebastian, MD, ScD

“…Abstract Background Benefit-risk assessment (BRA) methods can combine measures of benefits and risks into a single value. Objectives To examine BRA metrics for…”
Get full text

Assessing the strength of sinter by Bykov, M. S., Gubanov, V. I., Ivanov, V. M., Fedorov, V. G.

Get full text

Industrial production of metallized sinter by Bykov, M. S., Gubanov, V. I., Ivanov, V. M., Boriskin, I. K., Kostyshev, L. N.

Get full text